Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Borysowski

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Geroscience|February 23, 2024
Exclusion of older patients from randomized clinical trials in Parkinson's diseaseDanuta Kłosowska, Urszula Fiszer, Jarosław Dulski, et al.
Diabetes, Obesity & Metabolism|December 26, 2024
Exclusion of older persons from randomized controlled trials in type 2 diabetes: A cross-sectional studyJan Borysowski, Danuta Kłosowska, Leszek Pączek, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 5, 2011
Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectivesJan Borysowski, Małgorzata Lobocka, Ryszard Międzybrodzki, et al.
International Journal of Cancer|November 6, 2025
Exclusion of patients with renal impairment from phase 3 randomized controlled trials in hematologic malignanciesDanuta Kłosowska, Michał Ordak, Ewa Lech-Marańda, et al.
Cancer|March 16, 2026
Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancerJan Borysowski, Danuta Kłosowska, Marek Harhala, et al.
Biomed Research International|September 24, 2014
Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threatEwa Jończyk-Matysiak, Marlena Kłak, Beata Weber-Dąbrowska, et al.
Future Microbiology|April 14, 2015
T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitroMaciej Przybylski, Jan Borysowski, Renata Jakubowska-Zahorska, et al.
Frontiers in Immunology|May 15, 2018
"Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease?Andrzej Górski, Ewa Jończyk-Matysiak, Ryszard Międzybrodzki, et al.
Breast Cancer Research and Treatment|March 31, 2026
The use of endpoints in phase 3 randomized controlled trials in metastatic breast cancerWeronika Kupis, Danuta Kłosowska, Marek Harhala, et al.
Microorganisms|December 19, 2020
The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral?Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Maciej Żaczek, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Geroscience|February 23, 2024
Exclusion of older patients from randomized clinical trials in Parkinson's diseaseDanuta Kłosowska, Urszula Fiszer, Jarosław Dulski, et al.
Diabetes, Obesity & Metabolism|December 26, 2024
Exclusion of older persons from randomized controlled trials in type 2 diabetes: A cross-sectional studyJan Borysowski, Danuta Kłosowska, Leszek Pączek, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 5, 2011
Potential of bacteriophages and their lysins in the treatment of MRSA: current status and future perspectivesJan Borysowski, Małgorzata Lobocka, Ryszard Międzybrodzki, et al.
International Journal of Cancer|November 6, 2025
Exclusion of patients with renal impairment from phase 3 randomized controlled trials in hematologic malignanciesDanuta Kłosowska, Michał Ordak, Ewa Lech-Marańda, et al.
Cancer|March 16, 2026
Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancerJan Borysowski, Danuta Kłosowska, Marek Harhala, et al.
Biomed Research International|September 24, 2014
Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threatEwa Jończyk-Matysiak, Marlena Kłak, Beata Weber-Dąbrowska, et al.
Future Microbiology|April 14, 2015
T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitroMaciej Przybylski, Jan Borysowski, Renata Jakubowska-Zahorska, et al.
Frontiers in Immunology|May 15, 2018
"Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease?Andrzej Górski, Ewa Jończyk-Matysiak, Ryszard Międzybrodzki, et al.
Breast Cancer Research and Treatment|March 31, 2026
The use of endpoints in phase 3 randomized controlled trials in metastatic breast cancerWeronika Kupis, Danuta Kłosowska, Marek Harhala, et al.
Microorganisms|December 19, 2020
The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral?Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Maciej Żaczek, et al.
Pageof 6